Figure 9.
mDNAsi/mRNAsi associated with CSMD1 mutant status and clinicopathological characteristics. (A and B) Differences in mDNAsi/mRNAsi between tumor and normal group. (C and D) Differences in mDNAsi/mRNAsi between the CSMD1 mutant group and the wild group. (E/F) Differences in mDNAsi/mRNAsi between different subtypes of each clinicopathological.